Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
4
×
biotech
boston blog main
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
4
×
detroit blog main
detroit top stories
gilead sciences
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
novartis
4
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biogen
boston top stories
clinical trials
deals
gene therapy
glaxosmithkline
immunotherapy
startups
alzheimer's disease
cancer
What
bio
roundup
acquisitions
ceo
drug
abbvie’s
ahead
albert
announced
approval
biggest
biofourmis
biogen’s
biopharmaceutical
bourla
bucks
cancer
celebrate
chance
collabs
companies
company
convo
corner
covid
crispr
daniel
day
days
deal
earlier
failures
forward
future
gilead
gilead’s
help
holiday
imports
introduce
Language
unset
unknown
Current search:
novartis
×
abbvie
×
" cancer immunotherapy "
×
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More